T315I-mutated myeloid sarcoma
We report the first case of a patient with T315I mutated myeloid sarcoma that occurred after complete cytogenetic response with dasatinib of a chronic phase CML. The patient was successfully treated with induction chemotherapy and ponatinib.
Source: Leukemia Research Reports - Category: Hematology Source Type: research
More News: Chemotherapy | Chronic Leukemia | Chronic Myeloid Leukaemia | Genetics | Hematology | Leukemia | Sarcomas